BBC vs. EWK ETF Comparison
Comparison of Virtus LifeSci Biotech Clinical Trials ETF (BBC) to iShares MSCI Belgium Capped Investable Market Index Fund (EWK)
BBC
Virtus LifeSci Biotech Clinical Trials ETF
BBC Description
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
Grade (RS Rating)
Last Trade
$27.89
Average Daily Volume
4,165
Number of Holdings
*
90
* may have additional holdings in another (foreign) market
EWK
iShares MSCI Belgium Capped Investable Market Index Fund
EWK Description
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Belgium IMI 25/50 Index (the "underlying index"). The fund will at all times invest at least 80% of its assets in the securities of its underlying index and in depositary receipts ("DRs") representing securities in its underlying index. The underlying index is designed to measure broad-based equity market performance in Belgium. The fund is non-diversified.Grade (RS Rating)
Last Trade
$18.95
Average Daily Volume
17,376
Number of Holdings
*
3
* may have additional holdings in another (foreign) market
Performance
Period | BBC | EWK |
---|---|---|
30 Days | 0.79% | 0.88% |
60 Days | -9.86% | 3.91% |
90 Days | 7.96% | 5.12% |
12 Months | 15.48% | 1.26% |
0 Overlapping Holdings
Symbol | Grade | Weight in BBC | Weight in EWK | Overlap |
---|
BBC Overweight 90 Positions Relative to EWK
Symbol | Grade | Weight | |
---|---|---|---|
VKTX | C | 3.23% | |
ALPN | A | 2.82% | |
CGEM | A | 2.62% | |
RNA | A | 2.53% | |
VERA | C | 2.31% | |
SANA | C | 1.87% | |
DYN | D | 1.77% | |
GERN | B | 1.54% | |
MRUS | C | 1.47% | |
KROS | D | 1.43% | |
CYTK | D | 1.41% | |
LQDA | D | 1.41% | |
KURA | D | 1.38% | |
MGNX | D | 1.31% | |
BCYC | C | 1.28% | |
IOVA | D | 1.28% | |
IGMS | C | 1.23% | |
MLYS | D | 1.23% | |
SMMT | C | 1.21% | |
FDMT | D | 1.2% | |
RVMD | A | 1.17% | |
NRIX | D | 1.15% | |
KRYS | D | 1.12% | |
KYMR | D | 1.12% | |
COGT | C | 1.11% | |
ALXO | B | 1.06% | |
CRNX | A | 1.04% | |
INBX | D | 1.02% | |
PTGX | D | 1.01% | |
IDYA | D | 0.98% | |
DAWN | A | 0.95% | |
LYEL | C | 0.92% | |
ARDX | C | 0.92% | |
ANAB | B | 0.92% | |
PGEN | D | 0.91% | |
SNDX | D | 0.88% | |
PHAT | C | 0.86% | |
ALLO | F | 0.86% | |
CMPS | D | 0.86% | |
XENE | C | 0.85% | |
IMTX | D | 0.84% | |
CLDX | C | 0.84% | |
PCVX | D | 0.83% | |
XNCR | C | 0.82% | |
ACLX | D | 0.82% | |
ITOS | C | 0.82% | |
MORF | F | 0.78% | |
ARCT | F | 0.78% | |
BLTE | C | 0.76% | |
ARVN | D | 0.74% | |
ORIC | D | 0.74% | |
RCUS | F | 0.73% | |
AKRO | F | 0.72% | |
NUVL | D | 0.71% | |
RXRX | F | 0.71% | |
REPL | F | 0.7% | |
MDGL | D | 0.7% | |
VIR | C | 0.69% | |
DVAX | D | 0.69% | |
OLMA | F | 0.68% | |
ARWR | F | 0.67% | |
SRRK | C | 0.66% | |
TERN | F | 0.65% | |
ETNB | F | 0.65% | |
RCKT | D | 0.64% | |
ZNTL | F | 0.63% | |
BMEA | F | 0.63% | |
RGNX | F | 0.63% | |
NVAX | D | 0.62% | |
TGTX | C | 0.61% | |
BEAM | F | 0.61% | |
SAVA | B | 0.61% | |
PLRX | F | 0.59% | |
ABCL | F | 0.58% | |
VRDN | F | 0.58% | |
NTLA | F | 0.57% | |
DNLI | F | 0.55% | |
ALEC | F | 0.54% | |
RLAY | F | 0.54% | |
IMVT | F | 0.53% | |
CRBU | F | 0.5% | |
QURE | F | 0.45% | |
PRTA | F | 0.45% | |
CABA | F | 0.42% | |
EDIT | F | 0.41% | |
IRON | F | 0.4% | |
CVAC | D | 0.36% | |
VERV | F | 0.36% | |
RAPT | F | 0.34% | |
ALLK | F | 0.29% |
BBC: Top Represented Industries & Keywords
EWK: Top Represented Industries & Keywords
Industries:
Biotechnology
Gambling
Keywords:
Acute Myeloid Leukemia
Autoimmune Disease
Back Office Systems
Biopharmaceutical
Cancer
Cancer Immunotherapy
Casino
Corporate Social Responsibility
Dyslipidemia
Electronic Gaming Machines
Entertainment
Gambling
Gaming Products
Hematological Cancers
Immunotherapy
Inflammation
International Game Technology
Janus Kinase Inhibitor
Lipid
Lymphoma